(17 days)
The B. Braun Regional Anesthesia Catheter is a device intended to provide, via percutaneous administration, continuous and/or intermittent infusion of local anesthetics and analgesics in the epidural space or near a nerve for regional anesthesia and pain management during the pre- operative, perioperative and postoperative periods associated with general and orthopedic surgery as well as labor and delivery. Routes of administration include epidural and perineural (peripheral nerve block).
The B. Braun Regional Anesthesia Catheter is a co- extruded anesthesia conduction catheter consisting of an inner layer of polyamide and an outer layer of polyurethane. The catheter will range in length from 400 – 1010 millimeters and will be available in both 19 and 20 Ga. diameters. The catheter will be available in an open tip configuration as well as a closed tip configuration. The closed tip catheters will have a rounded closed tip with six side ports for distribution of anesthetics and analgesics. The catheter will also have depth markings beginning within 50.5 millimeters from the tip of the catheter and ending at approximately 250 millimeters from the tip.
The provided text is a 510(k) summary for a medical device, the B. Braun Regional Anesthesia Catheter. It describes the device, its intended use, and its substantial equivalence to predicate devices based on performance and functionality testing. However, it does not detail specific acceptance criteria or the study data in the format requested.
The document states that "The effect of these material and side port differences was evaluated by performance and functionality testing. The result of this testing does not raise any new issues of safety and effectiveness." This indicates that tests were performed to demonstrate that the new catheter performs comparably or acceptably, but the specifics of these tests (e.g., precise acceptance criteria, study sizes, ground truth, etc.) are not publicly available in this summary.
Therefore, many of the requested details cannot be extracted directly from this document.
Here's what can be gathered and what cannot:
1. A table of acceptance criteria and the reported device performance
The document broadly states that "performance and functionality testing" was conducted and "The result of this testing does not raise any new issues of safety and effectiveness." This implies that the device met the acceptance criteria established for safety and effectiveness, likely by demonstrating equivalence to the predicate devices in various performance aspects. However, the specific quantitative acceptance criteria (e.g., tensile strength minimum, flow rate range, radiopacity level) and measured performance values are not provided in this summary.
2. Sample sized used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
This information is not available in the provided text.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)
This information is not available in the provided text. The testing appears to be primarily engineering/functionality testing rather than clinical studies requiring expert ground truth in the typical sense of diagnostic accuracy.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
This information is not available in the provided text.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
An MRMC study is not applicable here. This is a medical device (catheter) clearance based on substantial equivalence, not an AI diagnostic algorithm.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
This is not applicable as it's not an AI algorithm.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)
Given the nature of the device (catheter), the "ground truth" for performance testing would likely involve engineering specifications, material properties, and functional benchmarks (e.g., flow rates, burst pressure, radiopacity, lubricity, mechanical strength), rather than clinical outcomes or expert consensus on diagnostic images. However, the specifics are not detailed. It's established by demonstrating "substantial equivalence" to predicate devices, implying these predicate devices are already considered safe and effective.
8. The sample size for the training set
This is not applicable as this is not an AI algorithm.
9. How the ground truth for the training set was established
This is not applicable as this is not an AI algorithm.
Summary of available information related to the "study" for acceptance:
- Study Type: Performance and functionality testing to demonstrate substantial equivalence.
- Purpose: To evaluate the effect of material and side port differences compared to predicate devices and confirm that these differences do not raise new issues of safety and effectiveness.
- Predicate Devices:
- Key Differences Evaluated:
- Co-extruded material (polyamide and polyurethane)
- Radiopaque stripes (three barium sulfate vs. one tungsten)
- Number of side ports (six vs. seven or three on predicate devices)
- Outcome: "The result of this testing does not raise any new issues of safety and effectiveness." This implies the device met the unstated acceptance criteria for performance and safety.
In essence, the document serves as a regulatory summary indicating that testing was performed and the results were satisfactory for clearance, but it does not provide the granular details of those tests requested in the prompt.
{0}------------------------------------------------
SEP 3 0 2004
- 3 510(k) Summary
| SUBMITTER: | B. Braun Medical Inc. 901 Marcon Boulevard Allentown, PA 18109-9341 (610) 266-0500, ext. 2597 Contact: Amy Smith, RAC |
|---|---|
| DEVICE NAME: | B. Braun Regional Anesthesia Catheter Epidural Tradename - Perifix® Catheter Peripheral Nerve Block Tradename - Contiplex® Catheter |
| COMMON OR USUAL NAME: | Epidural / Nerve Block Catheter |
| DEVICE CLASSIFICATION: | Anesthesia Conduction Catheter 21 CFR Part 868.5120, Product Code BSO |
| PREDICATE DEVICE: | Csen Ltd, Combined End-Multiple Lateral Hole Epidural Catheter, K951927 B. Braun Medical Inc., B. Braun Nerve Block Catheter, K030380 |
| DESCRIPTION: | The B. Braun Regional Anesthesia Catheter is a co- extruded anesthesia conduction catheter consisting of an inner layer of polyamide and an outer layer of polyurethane. The catheter will range in length from 400 – 1010 millimeters and will be available in both 19 and 20 Ga. diameters. The catheter will be available in an open tip configuration as well as a closed tip configuration. The closed tip catheters will have a rounded closed tip with six side ports for distribution of anesthetics and analgesics. The catheter will also have depth markings beginning within 50.5 millimeters from the tip of the catheter and ending at approximately 250 millimeters from the tip. |
| INTENDED USE: | The B. Braun Regional Anesthesia Catheter is a device intended to provide, via percutaneous administration, continuous and/or inter.nittent infusion of local anesthetics and analgesics in the epidural space or near a nerve for regional anesthesia and pain management during the pre- operative, perioperative and postoperative periods |
{1}------------------------------------------------
associated with general and orthopedic surgery as well as labor and delivery. Routes of administration include epidural and perineural (peripheral nerve block).
SUBSTANTIAL EQUIVALENCE:
The new B. Braun Regional Anesthesia catheter is similar in size, application, performance and sterilization methods to the B. Braun Nerve Block Catheter (K030830). Both of these catheters are available in open and closed tip configurations and are provided in the same lengths. The new B. Braun Regional Anesthesia catheter is similar in application and characteristics to the Csen Ltd Combined End-Multiple Lateral Holes Epidural catheter (K951927). Both of these catheters contain multiple side ports to allow for distribution of anesthetics and analgesics. The indications for use for the subject device combines both the epidural and peripheral nerve block applications of the predicate devices.
The new B. Braun Regional Anesthesia catheter is different from the predicate devices in that it is a coextruded catheter with both polyamine and polyurethane. Additionally, to aid in locating the device radiographically, three barium sulfate radiopaque stripes are included instead of only one tungsten stripe. The subject device also has six side port holes while the predicate devices have either seven or three. The effect of these material and side port differences was evaluated by performance and functionality testing. The result of this testing does not raise any new issues of safety and effectiveness.
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle or bird-like symbol with three curved lines representing its wings or body. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the bird symbol.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
SEP 3 0 2004
Ms. Amy Smith Senior Regulatory Affairs Specialist B. Braun Medical, Incorporated 901 Marcon Boulevard Allentown, Pennsylvania 18109-9341
Re: K042488
Trade/Device Name: B. Braun Regional Anesthesia Catheter Regulation Number: 21 CFR 868.5120 Regulation Name: Anesthesia Conduction Catheter Regulatory Class: II Product Code: BSO Dated: September 10, 2004 Received: September 13, 2004
Dear Ms. Smith:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Eederal Register.
{3}------------------------------------------------
Page 2 - Ms. Smith
Please be advised that FDA's issuance of a substantial equivalence determination does not I loase be advised that be a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. or the For ary I with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice and ilsuing (21 es result in the quality systems (QS) regulation (21 CFR Part 820); and if requirements as bectronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) I mis letter will are r Jearle FDA finding of substantial equivalence of your device to a promative nemily and device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), rl Jase contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the may overn of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Clus
Shu-Jen, Ph.D.
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
Indications for Use Statement 1.2
Page
| 510(k) Number (if known): | K042488 |
|---|---|
| --------------------------- | --------- |
Device Name:
B. Braun Regional Anesthesia Catheter
Indications For Use:
The B. Braun Regional Anesthesia Catheter is a device intended to provide, via percutaneous administration, continuous and/or intermittent infusion of local anesthetics perculancous administration, commac or near a nerve for regional anesthesia and pain management during the pre-operative and postoperative and postoperative periods associated with general and orthopedic surgery as well as labor and delivery. Routes of administration include epidural and perineural (peripheral nerve block).
Prescription Use _ X (Per 21 CFR 801.109)
OR
Over-The-Counter Use _
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
hom
(Division Sign-Off)
Division of Anesthesiology, General Hospital,
Infection Control, Dental Devices
510(k) Number: K042488
§ 868.5120 Anesthesia conduction catheter.
(a)
Identification. An anesthesia conduction catheter is a flexible tubular device used to inject local anesthetics into a patient and to provide continuous regional anesthesia.(b)
Classification. Class II (performance standards).